scispace - formally typeset
E

Erik Thai

Researcher at Cordis

Publications -  37
Citations -  4273

Erik Thai is an academic researcher from Cordis. The author has contributed to research in topics: Neuromodulation (medicine) & End stage renal disease. The author has an hindex of 17, co-authored 37 publications receiving 4273 citations.

Papers
More filters
Patent

Methods and systems for thermally-induced renal neuromodulation

TL;DR: In this article, thermally-induced renal neuromodulation is achieved via delivery of a pulsed thermal therapy, in which parameters of the neural fibers, of non-target tissue, or of the thermal energy delivery element, may be monitored via one or more sensors for controlling the thermallyinduced neuromodi modality.
Patent

Methods and apparatus for thermally-induced renal neuromodulation

TL;DR: In this article, thermally-induced renal neuromodulation is achieved via delivery of a pulsed thermal therapy, where the parameters of the neural fibers, of non-target tissue, or of the thermal energy delivery element, may be monitored via one or more sensors.
Patent

Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach

TL;DR: The ITEV PEF (Intravascular Pulsed Electric Field Neuromodulation) as mentioned in this paper is a PEF system that uses an intravascular catheter having one or more electrodes configured for intra-extravascular placement across a wall of patient's vessel into proximity with target neural fibers.
Patent

Methods and apparatus for intravascularly-induced neuromodulation or denervation

TL;DR: In this article, methods and apparatus are provided for intravascularly-induced neuromodulation or denervation. And in some embodiments, parameters of the target neural matter, of non-target tissue, or of the apparatus may be monitored via one or more sensors.
Patent

Apparatuses for renal neuromodulation

TL;DR: In this paper, a pulsed electric field was used to induce electroporation or electrofusion of percutaneous intravascular vessels to reduce expansion of an acute myocardial infarction, reduce or prevent the onset of morphological changes that are affiliated with congestive heart failure, and/or be efficacious in the treatment of end stage renal disease.